Literature DB >> 33500857

Drug-Induced Liver Injury Caused by Amoxicillin/Clavulanate.

Inês Ferreira1, Cláudio Gouveia1, Carolina Vasques1, Catarina Faria1, Ana Pedroso1.   

Abstract

Drug-induced liver injury (DILI) has a relatively low incidence, and as it is a diagnosis of exclusion, it can become quite a challenge for the clinician. Amoxicillin/clavulanate continues to be one of the most prescribed antibiotics and only rarely causes liver injury. We report a case of DILI associated with this antibiotic to bring attention to a rare side effect of a very commonly prescribed drug. This is the case of a 71-year-old man, with no relevant past medical history, who presented to the Emergency Department due to jaundice in the previous two weeks, with no immediate identifiable cause. The patient was admitted to our Internal Medicine Ward, and after getting a detailed clinical history and excluding other common and severe causes of liver injury, the diagnosis was made that liver injury was due to amoxicillin/clavulanate intake, thus demonstrating the importance of an in-depth history.
Copyright © 2020, Ferreira et al.

Entities:  

Keywords:  amoxicillin/clavulanate; drug; injury; jaundice; liver

Year:  2020        PMID: 33500857      PMCID: PMC7819498          DOI: 10.7759/cureus.12234

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Hepatotoxic reactions induced by beta-lactamase inhibitors.

Authors:  P Berg; E G Hahn
Journal:  Eur J Med Res       Date:  2001-12-17       Impact factor: 2.175

Review 2.  Drug-induced cholestasis.

Authors:  Einar S Bjornsson; Jon Gunnlaugur Jonasson
Journal:  Clin Liver Dis       Date:  2012-12-20       Impact factor: 6.126

3.  Corticosteroid therapy in a case of severe cholestasic hepatitis associated with amoxicillin-clavulanate.

Authors:  José-Ignacio Herrero-Herrero; Judit García-Aparicio
Journal:  J Med Toxicol       Date:  2010-12

4.  Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.

Authors:  Raúl J Andrade; M Isabel Lucena; Neil Kaplowitz; Beatriz García-Muņoz; Yolanda Borraz; Ketevan Pachkoria; Miren García-Cortés; M Carmen Fernández; Gloria Pelaez; Luis Rodrigo; José A Durán; Joan Costa; Ramón Planas; Anabel Barriocanal; Carlos Guarner; Manuel Romero-Gomez; Teresa Muņoz-Yagüe; Javier Salmerón; Ramón Hidalgo
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

5.  Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Authors:  Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

Authors:  J O'Donohue; K A Oien; P Donaldson; J Underhill; M Clare; R N MacSween; P R Mills
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

Review 7.  Epidemiology of idiosyncratic drug-induced liver injury.

Authors:  Lauren N Bell; Naga Chalasani
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115

8.  Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

Authors:  M Isabel Lucena; Raúl J Andrade; Neil Kaplowitz; Miren García-Cortes; M Carmen Fernández; Manuel Romero-Gomez; Miguel Bruguera; Hacibe Hallal; Mercedes Robles-Diaz; Jose F Rodriguez-González; Jose Maria Navarro; Javier Salmeron; Pedro Martinez-Odriozola; Ramón Pérez-Alvarez; Yolanda Borraz; Ramón Hidalgo
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

9.  Amoxicillin-Clavulanate-Induced Liver Injury.

Authors:  Andrew S deLemos; Marwan Ghabril; Don C Rockey; Jiezhun Gu; Huiman X Barnhart; Robert J Fontana; David E Kleiner; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

Review 10.  RUCAM in Drug and Herb Induced Liver Injury: The Update.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.